Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

S&P Pharmaceuticals SPDR (XPH)

S&P Pharmaceuticals SPDR (XPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Price/Earnings ttm 10.54
  • Annual Dividend & Yield 0.70 (1.53%)
  • Most Recent Dividend 0.195 on 09/23/24
  • Management Fee 0.35%
  • Sectors:

    ETFs - Biotech

Options Overview Details

View History
  • Implied Volatility 17.48% ( +1.01%)
  • Historical Volatility 20.10%
  • IV Percentile 28%
  • IV Rank 67.28%
  • IV High 24.83% on 08/14/24
  • IV Low 2.35% on 06/11/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 20
  • Volume Avg (30-Day) 41
  • Put/Call OI Ratio 3.32
  • Today's Open Interest 907
  • Open Int (30-Day) 1,186

Price Performance

See More
Period Period Low Period High Performance
1-Month
44.39 +4.87%
on 11/19/24
48.76 -4.53%
on 11/11/24
-0.10 (-0.21%)
since 10/21/24
3-Month
42.76 +8.86%
on 09/11/24
48.76 -4.53%
on 11/11/24
+2.59 (+5.89%)
since 08/21/24
52-Week
36.49 +27.57%
on 11/28/23
48.76 -4.53%
on 11/11/24
+9.98 (+27.29%)
since 11/21/23

Most Recent Stories

More News
What Are Wall Street Analysts' Target Price for Zoetis Stock?

Zoetis has significantly underperformed the broader market over the past year, yet analysts remain bullish on the stock’s prospects.

XPH : 46.41 (+1.98%)
$SPX : 5,952.60 (+0.60%)
JPM : 245.14 (+1.81%)
ZTS : 177.16 (+0.85%)
Are Wall Street Analysts Predicting Viatris Stock Will Climb or Sink?

Due to Viatris’ underperformance relative to the broader S&P 500 Index over the past year, Wall Street analysts remain cautious about the stock’s prospects.

XPH : 46.41 (+1.98%)
$SPX : 5,952.60 (+0.60%)
VTRS : 13.25 (+0.91%)
Do Wall Street Analysts Like Catalent Stock?

While Catalent has outperformed the broader market over the past year, analysts are cautious about the stock’s potential.

CTLT : 59.65 (+1.10%)
$SPX : 5,952.60 (+0.60%)
XPH : 46.41 (+1.98%)
BCS : 13.39 (+1.13%)
Zoetis Stock: Is Wall Street Bullish or Bearish?

Despite Zoetis lagging behind the broader market over the past year, analysts still remain strongly bullish on the stock’s prospects.

ZTS : 177.16 (+0.85%)
$SPX : 5,952.60 (+0.60%)
XPH : 46.41 (+1.98%)
How Is Bristol-Myers Squibb's Stock Performance Compared to Other General Drug Manufacturers?

Bristol-Myers Squibb has been lagging behind other drug manufacturers over the past three months, and analysts remain cautious about the stock's prospects.

BMY : 58.44 (+0.97%)
XPH : 46.41 (+1.98%)
AZN : 63.80 (+0.95%)
Do Wall Street Analysts Like Merck & Company Stock?

As Merck outperforms the broader market this year, Wall Street analysts remain optimistic about the stock's prospects.

MRK : 99.28 (+1.89%)
$SPX : 5,952.60 (+0.60%)
XPH : 46.41 (+1.98%)
How Much Pain Will Lower Medicare Prices Cause for Pharma Stocks?

Pharmaceutical stocks are holding steady as Medicare price negotiations approach, but industry diversification and innovation support future growth prospects.

AMGN : 290.37 (+0.87%)
BMY : 58.44 (+0.97%)
LLY : 750.81 (-0.35%)
XLV : 144.12 (+0.87%)
HZNP : 116.30 (+0.04%)
JNJ : 155.68 (+1.68%)
MRK : 99.28 (+1.89%)
NVS : 103.67 (+0.56%)
NVO : 102.91 (-2.24%)
XPH : 46.41 (+1.98%)
ALPMY : 10.1450 (+0.74%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The SPDR SP Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Pharmaceuticals Select Industry Index.

See More

Key Turning Points

3rd Resistance Point 45.99
2nd Resistance Point 45.76
1st Resistance Point 45.64
Last Price 46.41
1st Support Level 45.29
2nd Support Level 45.06
3rd Support Level 44.94

See More

52-Week High 48.76
Last Price 46.41
Fibonacci 61.8% 44.07
Fibonacci 50% 42.63
Fibonacci 38.2% 41.18
52-Week Low 36.49

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar